An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects
Clinical trial NCT02434861 · COMPLETED
Trial details
- NCT number
- NCT02434861
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.